Global Policy Forum

In presentations and after hours, free of organizational constraints and powered by dynamic conversations, the Global Policy Forum is unique.

To maintain and foster energetic conversation, Global Policy Forum membership is limited. Applications are accepted when a call for expressions of interest is opened.

Background Papers & Articles Presentations

HTAi Global Policy Forum 2025 (1600 x 1200 px) (1)

Global Policy Forum Dates & Locations

  • Montréal, Canada (January 25-27, 2026)
  • Cascais, Portugal (January 26-28, 2025)
  • San Diego, United States of America (January 27-29, 2024)
  • The Hague, Netherlands (March 26-28, 2023)
  • Vancouver, Canada (March, 26-28, 2022)
  • Virtual (February 22-26, 2021)

Global Policy Forum Members

  1. Abbott Vascular
  2. AMGEN (Europe) GmbH
  3. AstraZeneca (UK) Ltd
  4. BioMarin Pharmaceutical Inc
  5. Boehringer Ingelheim
  6. Boston Scientific Corporation
  7. Bristol-Myers Squibb
  8. Edwards Lifesciences
  9. Eli Lilly and Company
  10. F. Hoffmann-La Roche AG
  11. GlaxoSmithKline
  12. Johnson & Johnson
  13. Medtronic
  14. Merck & Co
  15. Merck KGaA
  16. Novartis Pharma AG
  17. Pfizer Limited
  18. Sanofi Genzyme
  19. W. L. Gore & Associates 
  1. AGENAS – Agenzia Nazionale per i Servizi Sanitari Regionali (Italy)
  2. AHTA – Adelaide Health Technology Assessment (University of Adelaide)
  3. AQuaS – Agency of Health Quality and Assessment of Catalonia (Spain)
  4. BC Cancer (Canada)
  5. CADTH – Canadian Agency for Drugs and Technologies in Health (Canada)
  6. CONITEC – National Committee for Technology Incorporation (Brazil)
  7. Healthcare Improvement Scotland (UK)
  8. ICER – Institute for Clinical & Economic Review (USA)
  9. IETS – Institute of Technological Evaluation in Health (Colombia)
  10. INESS – The Institut National D’Excellence en Santé et en Services Sociaux (Canada)
  11. INFARMED – National Authority of Medicines and Health Products, IP
  12. IQWiG – Institute for Quality and Efficiency in Health Care (Germany)
  13. NECA – National Evidence-based Healthcare Collaborating Agency (South Korea)
  14. NICE – National Institute for Health and Care Excellence (UK)
  15. NoMA – Norwegian Medical Products Agency (Norway)
  16. PBAC & MSAC Australia Government, Department of Health and Ageing (Australia)
  17. PCORI – Patient-Centered Outcomes Research Institute (USA)
  18. Swedish Dental and Pharmaceutical Benefits Agency (TLV) – (Sweden)
  19. ZINL – National Health Care Institute (Netherlands)

Global Policy Forum Background Papers and IJTAHC Articles

2025 Background Paper

The Journey to the Digitalization of Health Technology Assessment: The Role of Artificial Intelligence in HTA Lifecycle Activities

2024 Journal Article

Designing Collaborations Involving HTA: Finding The Rhythm For Success

2024 Background Paper

Designing Collaborations Involving HTA: Finding The Rhythm For Success

2023 Journal Article

The value and impact of health technology assessment: discussions and recommendations from the 2023 Health Technology Assessment International Global Policy Forum

2022 Journal Article

Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment

2021 Journal Article

Considering and communicating uncertainty in health technology assessment

2020 Journal Article

Principles for Deliberative Processes in Health Technology Assessment

2019 Journal Article

How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes – From Theory to Action

2018 Journal Article

How can health systems prepare for new and emerging health technologies? The role of horizon scanning revisited

2017 Journal Article

Developments in Value Frameworks to inform the allocation of healthcare resources

2016 Journal Article

Changing Health Technology Assessment Paradigms

2015 Journal Article

Improving the Effectiveness and Efficiency of Evidence Production for Health Technology Assessment

2014 Journal Article

Adaptive Approaches to Licensing, Health Technology Assessment, and Introduction of Drugs and Devices

2013 Journal Article

Health Technology Assessment, Value-based Decision Making, and Innovation

2012 Journal Article

Using Health Technology Assessment to Support Optimal Use of Technologies in Current Practice: The Challenge of “Disinvestment

2011 Journal Article

Interactions Between Health Technology Assessment, Coverage, And Regulatory Processes: Emerging Issues, Goals and Opportunities

2010 Journal Article

What Principles Should Govern The Use Of Managed Entry Agreements?

2009 Journal Article

HTA To Optimize Health Technology Utilization: Using Implementation Initiatives And Monitoring Processes

2008 Journal Article

Harmonization Of Evidence Requirements In HTA For Reimbursement Decision-making

2007 Journal Article

Coverage With Evidence Development: An Examination Of Conceptual And Policy Issues

Global Policy Forum Presentations

2022 Presentation

Global Policy Forum Topic Scoping

2021 Presentation

Annual Meeting Panel

2021 Presentation

Global Policy Forum Topic Scoping

2020 Presentation

Annual Meeting Panel

Policy Forum Events

HTAi 2026 Global Policy Forum

January 25, 2026 8:00 am
March 21 8:18 pm HTAi Policy Forums provide the opportunity to interact and network with various stakeholders on a one-on-one basis, have open group discussions…
Read Moreabout HTAi 2026 Global Policy Forum

2024 Global Policy Forum

January 27, 2024
March 21 8:18 pm HTAi Policy Forums provide the opportunity to interact and network with various stakeholders on a one-on-one basis, have open group discussions…
Read Moreabout 2024 Global Policy Forum

Global Policy Forum

March 26, 2023
March 21 8:18 pm Learn about the Global Policy Forum. Add to calendar Google Calendar iCalendar Outlook 365 Outlook Live Details Date: March 21, 2025…
Read Moreabout Global Policy Forum